top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Inhibitors
Anticancer Inhibitors
Autore Fantacuzzi Marialuigia
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (216 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato breast cancer
tamoxifen
LY294002
synergism
apoptosis
cell cycle
tea (Camellia sinensis) flowers
BTFS
A2780/CP70 ovarian cancer cells
S phase cell cycle arrest
nicotinamide phosphoribosyltransferase
NAD+ biosynthesis
inhibitor
azacyclohexane
anticancer drug
drug design
enthalpy effect
NSCLC
Cathepsin K
cell proliferation
cell migration
cell invasion
mTOR
isatin-hydrazones
cytotoxicity
CDK2 inhibitor
ATP competitive inhibitor
ADME analysis
receptor tyrosine kinases
protein-protein interactions
protein engineering
directed evolution
angiogenesis
binding affinity
agonistic activity
saponins
phytochemicals
tea (Camellia sinensis) flower
ovarian cancer
autophagy
ZMYND8
tumorigenesis
epigenetic regulation
pro-oncogenic effects
tumor suppression
tacrine-coumarin derivatives
DNA
topoisomerases I, II
lung carcinoma cells
A549
chemotherapy
prodrug
drug targeting
overexpressed enzymes
ADC
ADEPT
GDEPT
LEAPT
PROTAC
cyclin-dependent kinase
cancer
resistance
small molecule inhibitors
PROTACs
statins
pancreatic cancer
DNA microarray
pitavastatin
cerivastatin
simvastatin
fluvastatin
atorvastatin
pravastatin
HMG-CoA reductase inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595069203321
Fantacuzzi Marialuigia  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumor and Anti-HIV Agents from Natural Products
Antitumor and Anti-HIV Agents from Natural Products
Autore Nakagawa-Goto Kyoko
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (338 p.)
Soggetto topico Research & information: general
Soggetto non controllato natural phaeosphaeride A
antitumor activity
human tumor cell lines
HEF cell line
acute toxicity
aspidosperma-type
monoterpenoid indole alkaloids
antiproliferative activity
tubulin inhibitor
Bousigonia mekongensis
ursolic acid
DOTA
triterpenoids
cytotoxicity
diterpenoid alkaloids
human tumor cells
lipojesaconitine
delcosine
delpheline
kobusine
pseudokobusine
BRAF inhibitor
Mentha aquatica var. Kenting Water Mint
essential oil
chemoprevention
two-stage skin carcinogenesis
melanoma
curcumin analog
apoptosis
oxidative stress
drug–drug interaction
tamoxifen
taxol
cisplatin
Artemisia absinthium L.
antioxidants
total phenolic content
melanoma and breast cancer cell line
HaCaT cells
inflammation
breast cancer
cell cycle
flavonoids
reactive oxygen species
tumor suppression
antiretroviral agents
anti-HIV
marine metabolites
natural products
drug development
Ivalin
Carpesium divaricatum
hepatocellular carcinoma
mitochondria-mediated apoptosis
NF-κB
Hernandia nymphaeifolia
butanolides
lignan glycosides
coumarins
antiangiogenic
cancer
natural agents
chemistry
medicine
cancer stem cell
cervical cancer
pterostilbene
resveratrol
caffeic acid
cancer multidrug resistance
P-glycoprotein
phenolic acid
oxypeucedanin
Angelica dahurica
antiproliferation
G2/M phase cell cycle arrest
p53
SK-Hep-1
hepatoma cells
allyl isothiocyanate
benzyl isothiocyanate
sulforaphane
phenethyl isothiocyanate
bladder cancer
quercetin
oral squamous cell carcinoma cells
metastasis
cell cycle arrest
epithelial-to-mesenchymal transition
matrix metalloproteinase
transforming growth factor-β1
β-lapachone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557504803321
Nakagawa-Goto Kyoko  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Autore Moriggl Richard
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (578 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato multiple myeloma
STAT3
S3I-1757
nanoparticle
CD38
siRNA/RNAi
polyethylenimine
PEI
lipopolyplex
siRNA delivery
glioma
glioblastoma
STAT5
AKT
ERK1/2
prolactin
androgens
prostate cancer
knockout
escape mechanisms
stem/progenitor cells
cell hierarchy
cancer
CD4+ T cells
CD8+ T cells
myeloid cells
immune check point
hepatitis C virus (HCV)
cirrhosis
hepatocellular carcinoma (HCC)
endoplasmic reticulum (ER) stress
oxidative stress (OS)
unfolded protein response (UPR)
microRNA-122 (miR-122)
nuclear factor erythroid 2-related factor 2 (NRF2)
signal transducer and activator of transcription 3 (STAT3)
hepatocyte nuclear factor 4 alpha (HNF4A)
solid cancers
cell cycle
apoptosis
inflammation
mitochondria
stemness
tumor suppression
melanoma
autoimmune disease
immunotherapy
tumor-immune cell interactions
breast cancer
PD-L1
M2 macrophages
NK cells
STAT3 inhibitor XIII
hedging
transaction costs
dynamic programming
risk management
post-decision state variable
cancer progression
cancer-stem cell
cytokine
therapy resistance
metastasis
immunosuppression
tumor microenvironment
proliferation
tyrosine kinase 2
JAK family of protein tyrosine kinases
signal transducer and activator of transcription
cytokine receptor signaling
gain-of-function mutation
tumorigenesis
ADAM17
interleukin-6
trans-signaling
epidermal growth factor receptor (EGF-R)
shedding
metalloprotease
tumor necrosis factor alpha (TNFα)
inflammation associated cancer
colon cancer
lung cancer
SH2 domain
mutations
autosomal-dominant hyper IgE syndrome
inflammatory hepatocellular adenomas
T-cell large granular lymphocytic leukemia
T-cell prolymphocytic leukemia
growth hormone insensitivity syndrome
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
targeting
tumor-associated macrophages
adoptive T cell therapy
immune suppression
STAT transcription factors
JAK
STAT
T-PLL
T-cell leukemia
meta-analysis
STAT5B signaling
small-molecule inhibitors
cancer models
companion animals
comparative oncology
pharmacological inhibitor
STAT5 signaling
chemotherapy resistance
myeloid leukemia
heat shock proteins
chaperones
stabilization
targeted therapy
ovarian cancer
hematopoietic cancers
therapeutic targeting
pharmacological inhibitors
mTOR
Bone Marrow Failure Syndromes
lymphocytes
lymphoma
T-cells
RHOA
NGS
MPN
JAK2 V617F
neoplastic stem cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Moriggl Richard  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui